Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

NCT06084338 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

FED

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: stereotactic ablative radiotherapy
DRUG: Pluvicto
DRUG: topical testosterone

Sponsor

VA Office of Research and Development